SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AC4. A total of 61 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,421 | – | 30,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| READYSTATE ASSET MANAGEMENT LP | 9,000,000 | $10,417,500 | 2.55% |
| Opti Capital Management, LP | 20,000,000 | $23,138,600 | 2.00% |
| Boussard & Gavaudan Investment Management LLP | 12,150 | $13,886,602 | 1.54% |
| SSI INVESTMENT MANAGEMENT LLC | 19,470,000 | $22,439,180 | 1.42% |
| LINDEN ADVISORS LP | 106,250,000 | $122,850,972 | 1.29% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 36,000,000 | $41,581 | 1.14% |
| Polar Asset Management Partners Inc. | 80,000,000 | $92,493,857 | 1.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 77,475,000 | $89,617,793 | 0.93% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 30,000,000 | $34,822,164 | 0.83% |
| WHITEBOX ADVISORS LLC | 14,870,000 | $17,137,675 | 0.47% |